REVB
Price
$2.82
Change
+$0.15 (+5.62%)
Updated
Apr 3, 04:35 PM (EDT)
Capitalization
2.42M
TSHA
Price
$1.27
Change
-$0.05 (-3.79%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
270.6M
34 days until earnings call
Ad is loading...

REVB vs TSHA

Header iconREVB vs TSHA Comparison
Open Charts REVB vs TSHABanner chart's image
Revelation Biosciences
Price$2.82
Change+$0.15 (+5.62%)
Volume$100
Capitalization2.42M
Taysha Gene Therapies
Price$1.27
Change-$0.05 (-3.79%)
Volume$28.04K
Capitalization270.6M
REVB vs TSHA Comparison Chart
Loading...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REVB vs. TSHA commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REVB is a Hold and TSHA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (REVB: $2.67 vs. TSHA: $1.32)
Brand notoriety: REVB and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REVB: 11% vs. TSHA: 75%
Market capitalization -- REVB: $2.42M vs. TSHA: $260.35M
REVB [@Biotechnology] is valued at $2.42M. TSHA’s [@Biotechnology] market capitalization is $260.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REVB’s FA Score shows that 2 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • REVB’s FA Score: 2 green, 3 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, REVB is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REVB’s TA Score shows that 3 TA indicator(s) are bullish while TSHA’s TA Score has 5 bullish TA indicator(s).

  • REVB’s TA Score: 3 bullish, 2 bearish.
  • TSHA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, REVB is a better buy in the short-term than TSHA.

Price Growth

REVB (@Biotechnology) experienced а -5.65% price change this week, while TSHA (@Biotechnology) price change was -26.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

REVB is expected to report earnings on Mar 01, 2023.

TSHA is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($271M) has a higher market cap than REVB($2.42M). TSHA YTD gains are higher at: -23.699 vs. REVB (-63.802). REVB has higher annual earnings (EBITDA): -7.95M vs. TSHA (-87.95M). TSHA has more cash in the bank: 139M vs. REVB (6.5M). REVB has less debt than TSHA: REVB (0) vs TSHA (63.2M). TSHA has higher revenues than REVB: TSHA (8.33M) vs REVB (0).
REVBTSHAREVB / TSHA
Capitalization2.42M271M1%
EBITDA-7.95M-87.95M9%
Gain YTD-63.802-23.699269%
P/E RatioN/A2.70-
Revenue08.33M-
Total Cash6.5M139M5%
Total Debt063.2M-
TECHNICAL ANALYSIS
Technical Analysis
REVBTSHA
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FEIM15.740.38
+2.47%
Frequency Electronics
ALKT26.920.39
+1.47%
Alkami Technology
ESTC91.390.05
+0.05%
Elastic NV
SD11.38-0.07
-0.61%
SandRidge Energy
NAOV2.56-0.49
-16.07%
NanoVibronix Inc

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
+2.69%
GNPX - REVB
48%
Loosely correlated
+28.21%
TCRT - REVB
46%
Loosely correlated
+29.63%
CRIS - REVB
36%
Loosely correlated
+1.37%
TOVX - REVB
31%
Poorly correlated
+5.36%
TSHA - REVB
31%
Poorly correlated
+4.35%
More